Clinical trial of molecular therapy for muscular dystrophy yields significant positive results
A molecular technique originally developed at the University of North Carolina at Chapel Hill has taken one step closer to becoming a treatment for the devastating genetic disease Duchenne muscular dystrophy.
Jul 25, 2011
0
0